240 related articles for article (PubMed ID: 26036739)
1. [Organisational determinants of adherence to secondary prevention medications after acute myocardial infarction].
Perrone E; Lenzi J; Avaldi VM; Castaldini I; Protonotari A; Rucci P; Piccinni C; Morini M; Fantini MP
Epidemiol Prev; 2015; 39(2):106-14. PubMed ID: 26036739
[TBL] [Abstract][Full Text] [Related]
2. Chronic polytherapy after myocardial infarction: the trade-off between hospital and community-based providers in determining adherence to medication.
Di Martino M; Alagna M; Lallo A; Gilmore KJ; Francesconi P; Profili F; Scondotto S; Fantaci G; Trifirò G; Isgrò V; Davoli M; Fusco D
BMC Cardiovasc Disord; 2021 Apr; 21(1):180. PubMed ID: 33853534
[TBL] [Abstract][Full Text] [Related]
3. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
[TBL] [Abstract][Full Text] [Related]
5. The impact of in-hospital cardiac rehabilitation program on medication adherence and clinical outcomes in patients with acute myocardial infarction in the Lazio region of Italy.
Soldati S; Di Martino M; Rosa AC; Fusco D; Davoli M; Mureddu GF
BMC Cardiovasc Disord; 2021 Sep; 21(1):466. PubMed ID: 34565326
[TBL] [Abstract][Full Text] [Related]
6. Adherence to evidence-based drug therapies after myocardial infarction: is geographic variation related to hospital of discharge or primary care providers? A cross-classified multilevel design.
Di Martino M; Alagna M; Cappai G; Mataloni F; Lallo A; Perucci CA; Davoli M; Fusco D
BMJ Open; 2016 Apr; 6(4):e010926. PubMed ID: 27044584
[TBL] [Abstract][Full Text] [Related]
7. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
Korhonen MJ; Robinson JG; Annis IE; Hickson RP; Bell JS; Hartikainen J; Fang G
J Am Coll Cardiol; 2017 Sep; 70(13):1543-1554. PubMed ID: 28935030
[TBL] [Abstract][Full Text] [Related]
8. Does age modify the relationship between adherence to secondary prevention medications and mortality after acute myocardial infarction? A nested case-control study.
Lenzi J; Rucci P; Castaldini I; Protonotari A; Di Pasquale G; Di Martino M; Perrone E; Forti P; Fantini MP
Eur J Clin Pharmacol; 2015 Feb; 71(2):243-50. PubMed ID: 25529226
[TBL] [Abstract][Full Text] [Related]
9. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
[TBL] [Abstract][Full Text] [Related]
10. Optimizing prevention and guideline-concordant care in Montenegro.
Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
[TBL] [Abstract][Full Text] [Related]
11. The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction.
Di Martino M; Kirchmayer U; Agabiti N; Bauleo L; Fusco D; Perucci CA; Davoli M
BMJ Open; 2015 Jun; 5(6):e007866. PubMed ID: 26063569
[TBL] [Abstract][Full Text] [Related]
12. Determinants of adherence to evidence-based therapy after acute myocardial infarction.
Hamood H; Hamood R; Green MS; Almog R
Eur J Prev Cardiol; 2016 Jun; 23(9):975-85. PubMed ID: 26198723
[TBL] [Abstract][Full Text] [Related]
13. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
[TBL] [Abstract][Full Text] [Related]
15. Association of long-term adherence to evidence-based combination drug therapy after acute myocardial infarction with all-cause mortality. A prospective cohort study based on claims data.
Kuepper-Nybelen J; Hellmich M; Abbas S; Ihle P; Griebenow R; Schubert I
Eur J Clin Pharmacol; 2012 Oct; 68(10):1451-60. PubMed ID: 22476389
[TBL] [Abstract][Full Text] [Related]
16. Medication use in long-term survivors from the MONICA/KORA Myocardial Infarction Registry.
Amann U; Kirchberger I; Heier M; Thilo C; Kuch B; Meisinger C
Eur J Intern Med; 2018 Jan; 47():62-68. PubMed ID: 28826823
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of secondary prevention medication after myocardial infarction - the role of general practitioners and patients.
Bally K; Buechel RR; Buser P; Tschudia P; Martinaa B; Zeller A
Swiss Med Wkly; 2013; 143():w13896. PubMed ID: 24193548
[TBL] [Abstract][Full Text] [Related]
18. Adherence to agents acting on the renin-angiotensin system in secondary prevention of non-fatal myocardial infarction: a self-controlled case-series study.
Ortolani P; Di Bartolomeo S; Marino M; Vagnarelli F; Guastaroba P; Rapezzi C; De Palma R
Eur Heart J Cardiovasc Pharmacother; 2015 Oct; 1(4):254-9. PubMed ID: 27532449
[TBL] [Abstract][Full Text] [Related]
19. Post-myocardial Infarction (MI) Care: Medication Adherence for Secondary Prevention After MI in a Large Real-world Population.
Huber CA; Meyer MR; Steffel J; Blozik E; Reich O; Rosemann T
Clin Ther; 2019 Jan; 41(1):107-117. PubMed ID: 30591287
[TBL] [Abstract][Full Text] [Related]
20. Adherence to ACC/AHA performance measures for myocardial infarction in six Middle-Eastern countries: association with in-hospital mortality and clinical characteristics.
Longenecker JC; Alfaddagh A; Zubaid M; Rashed W; Ridha M; Alenezi F; Alhamdan R; Akbar M; Bulbanat BY; Al-Suwaidi J
Int J Cardiol; 2013 Aug; 167(4):1406-11. PubMed ID: 22578736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
